KDM1A and acute myeloid leukemia: In an acute myeloid leukemia murine model of non-genetic resistance to inhibitors of the bromodomain and extra-terminal (BET) family of proteins, Bell et al. found that targeting of the lysine-specific histone demethylase 1 (LSD1) can induce the formation of new enhancers and restore sensitivity to the drug.